无异常子宫出血女性子宫内膜病变的超声特征:国际子宫内膜肿瘤分析研究(IETA3)结果
这项前瞻性观察研究纳入1745例无异常子宫出血(AUB)女性,采用IETA术语描述子宫内膜病变超声特征。组织学显示子宫内膜癌和/或EIN 29例(1.7%),息肉1028例(58.9%)。与有症状者相比,无AUB的子宫内膜癌患者内膜更薄且血供更少。
要点
- 无AUB女性中子宫内膜癌或EIN占1.7%,其中86.2%在绝经后诊断。
- 无AUB的子宫内膜癌或EIN平均内膜厚度11.2 mm(95%CI 8.9-13.6 mm),较良性病变厚2.4 mm(95%CI 0.3-4.6 mm)。
- 无AUB的子宫内膜息肉最常见血管模式为单根优势血管(64.8%)。
核心结论
- 采用IETA术语描述了无AUB女性子宫内膜癌、息肉及其他宫腔病变的典型超声特征。
- 无AUB的息肉或子宫内膜恶性肿瘤可能比有症状者内膜更薄且血供更少。
研究设计与样本
- 前瞻性观察研究,2011年至2018年在7个妇科超声专科中心纳入因非AUB指征就诊的女性。
- 共纳入1745例无AUB女性,其中1537例接受子宫内膜取样组织学诊断,208例随访至少1年。
- 858例(49.2%)为绝经前,887例(50.8%)为绝经后。
- 所有患者接受经阴道超声检查,采用IETA检查与测量技术,超声所见按IETA术语描述。
- 将本队列发现与2012年至2015年采用相同IETA技术检查的有AUB女性已发表队列进行比较。
主要发现
- 组织学显示子宫内膜癌和/或EIN 29例(1.7%),子宫内膜息肉1028例(58.9%),宫腔肌瘤66例(3.8%),增生期或分泌期内膜或无 atypia 增生144例(8.3%),子宫内膜萎缩265例(15.2%),组织不足5例(0.3%)。
- 子宫内膜癌或EIN病例中25/29(86.2%)在绝经后诊断。
- 子宫内膜癌或EIN女性平均内膜厚度11.2 mm(95%CI 8.9-13.6 mm),较良性病变平均厚2.4 mm(95%CI 0.3-4.6 mm)。
- 子宫内膜癌或EIN女性非均匀回声占比22/29(75.9%),良性病变为929/1716(54.1%),差值+21.8%(95%CI +4.2%至+39.2%)。
- 子宫内膜癌或EIN女性中度至丰富血流(color score 3-4)占31.0%(9/29),良性结局为12.8%(220/1716),差值+18.2%(95%CI -0.5%至+36.9%)。
临床怎么用
- 作者描述的无AUB女性子宫内膜癌、息肉及其他宫腔病变的IETA超声特征可用于临床识别。
- 作者认为无AUB的息肉或子宫内膜恶性肿瘤可能表现为内膜更薄且血供更少。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The primary aim of this study was to describe the ultrasound features of various endometrial and other intracavitary pathologies in women without abnormal uterine bleeding (AUB) using the International Endometrial Tumor Analysis (IETA) terminology. The secondary aim was to compare our findings with published data on women with AUB. METHODS: This was a prospective observational study of women presenting at one of seven centers specialized in gynecological ultrasonography, from 2011 until 2018, for indications unrelated to AUB. All patients underwent transvaginal ultrasound using the IETA examination and measurement techniques. Ultrasonography was performed as part of routine gynecological examination or follow-up of non-endometrial pathology, or as part of the work-up before undergoing treatment for infertility, uterine prolapse or ovarian pathology. Ultrasound findings were described using the IETA terminology. Endometrial sampling was performed after the ultrasound scan. The histological endpoints were endometrial atrophy, proliferative or secretory endometrium, endometrial hyperplasia without atypia, endometrial polyp, intracavitary leiomyoma, endometrial intraepithelial neoplasia (EIN), endometrial cancer (EC) and insufficient tissue. The findings in our cohort of women without AUB were compared with those in a published cohort of women with AUB who were examined with transvaginal ultrasound between 2012 and 2015 using the same IETA examination technique and terminology. RESULTS: In this study (IETA3), we included 1745 women without AUB who underwent a standardized transvaginal ultrasound examination followed by either endometrial sampling with histological diagnosis (n = 1537) or at least 1 year of clinical and ultrasound follow-up (n = 208). Of these, 858 (49.2%) women were premenopausal and 887 (50.8%) were postmenopausal. Histology showed the presence of EC and/or EIN in 29 (1.7%) women, endometrial polyps in 1028 (58.9%), intracavitary myomas in 66 (3.8%), proliferative or secretory changes or hyperplasia without atypia in 144 (8.3%), endometrial atrophy in 265 (15.2%) and insufficient tissue in five (0.3%). Most cases of EC or EIN (25/29 (86.2%)) were diagnosed after menopause. The mean endometrial thickness in women with EC or EIN was 11.2 mm (95% CI, 8.9-13.6 mm), being on average 2.4 mm (95% CI, 0.3-4.6 mm) thicker than their benign counterparts. Women with malignant endometrial pathology manifested more frequently non-uniform echogenicity (22/29 (75.9%)) than did those with benign endometrial pathology (929/1716 (54.1%)) (difference, +21.8% (95% CI, +4.2% to +39.2%)). Moderate to abundant vascularization (color score 3-4) was seen in 31.0% (9/29) of cases with EC or EIN compared with 12.8% (220/1716) of those with a benign outcome (difference, +18.2% (95% CI, -0.5% to +36.9%)). Multiple multifocal vessels were recorded in 24.1% (7/29) women with EC or EIN vs 4.0% (68/1716) of those with a benign outcome (difference, +20.2% (95% CI, +4.6% to +35.7%)). A regular endometrial-myometrial junction was seen less frequently in women with EC or EIN (19/29 (65.5%)) vs those with a benign outcome (1412/1716 (82.3%)) (difference, -16.8% (95% CI, -34.2% to +0.6%)). In women with endometrial polyps without AUB, a single dominant vessel was the most frequent vascular pattern (666/1028 (64.8%)). In women with EC, both in those with and those without AUB, the endometrium usually manifested heterogeneous echogenicity, but the endometrium was on average 8.6 mm (95% CI, 5.2-12.0 mm) thinner and less intensely vascularized (color score 3-4: difference, -26.8% (95% CI, -52.2% to -1.3%)) in women without compared to those with AUB. In both pre- and postmenopausal women, asymptomatic endometrial polyps were associated with a thinner endometrium, and they manifested more frequently a bright edge, a regular endometrial-myometrial junction and a single dominant vessel than did polyps in symptomatic women, and they were less intensely vascularized. CONCLUSIONS: We describe the typical ultrasound features of EC, polyps and other intracavitary histologies using IETA terminology in women without AUB. Our findings suggest that the presence of asymptomatic polyps or endometrial malignancy may be accompanied by thinner and less intensely vascularized endometria than their symptomatic counterparts. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Heremans R, Van Den Bosch T, Valentin L, et al. Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3). Ultrasound Obstet Gynecol. 2022. PMID: 35385178. doi:10.1002/uog.24910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。